Dog Degenerative Myelopathy Test

Early Genetic Risk Assessment for Progressive Spinal Cord Neurodegeneration

Canine Degenerative Myelopathy (DM) is a progressive, incurable disease of the spinal cord that causes gradual loss of coordination, hind limb weakness, and eventual paralysis in adult and senior dogs. Highly analogous to Amyotrophic Lateral Sclerosis (ALS) in humans, DM often progresses silently until clinical signs appear in dogs aged 8 years or older. The Degenerative Myelopathy Test identifies mutations in the SOD1 gene, allowing pet parents to determine if their dog is clear, a carrier, or at high risk. Early detection enables proactive mobility management, customized physical rehabilitation, and specialized supportive care long before symptoms compromise the dog's quality of life.

Core Medical & Biometric Capabilities

• SOD1 Gene Mutation Detection: Identifies normal, carrier, or mutated status associated with canine degenerative myelopathy.

• Early Neurodegenerative Warning: Allows early intervention with mobility aids, laser therapy, and targeted neuro-supportive supplements.

• High-Risk Breed Profiling: Recommended for German Shepherds, Pembroke Welsh Corgis, Boxers, Bernese Mountain Dogs, and Golden Retrievers.

• Non-Invasive DNA Swab: Quick cheek swab collection yielding definitive genetic risk results.